Older Adults (Over 50) As people age, the stomach produces less hydrochloric acid, which is needed to release B12 from food proteins
Start with tirzepatide monotherapy, titrate to therapeutic dose (12.515mg weekly), allow 1620 weeks to reach plateau, then reassess
The choice between subcutaneous and intramuscular administration may depend on the formulation, the patients body composition, and the clinics experience
Who May Consider B12 Injections B12 injections may be considered for individuals with low or borderline B12 levels or conditions that affect absorption , including reduced stomach acid, autoimmune factors, or gastrointestinal disorders
The most comprehensive study, published in BioMed Research International (2021), found that 5-amino-1MQ treatment "reverses diet-induced obesity and related T2D" in obese mice
Nitrous oxide prevents your body from absorbing B12